Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan has announced that its subsidiary, Mylan Pharmaceuticals, has received tentative approval from the FDA for its abbreviated new drug application for Linezolid tablets, 600mg.
Subscribe to our email newsletter
Linezolid tablets, an antibiotic, are the generic version of Pharmacia and Upjohn’s Zyvox tablets.
Currently, Mylan has 93 abbreviated new drug applications pending FDA approval, 21 of which are potential first-to-file opportunities.